Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.5610.988.726.2411.72

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹99.5 Cr -3.4% -13.6% -74.6% Stock Analytics
ADANI ENTERPRISES ₹250,386.0 Cr -1.2% -13.6% -6.8% Stock Analytics
REDINGTON ₹17,144.3 Cr -6.5% -15.9% 3% Stock Analytics
MMTC ₹9,058.5 Cr 13.5% -4.9% 25.2% Stock Analytics
HONASA CONSUMER ₹9,011.1 Cr 2.9% -8% 34.7% Stock Analytics
LLOYDS ENTERPRISES ₹6,935.1 Cr -4.6% -20.6% 32.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-3.4%

-13.6%

-74.6%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses